Drug
Morab 202
Morab 202: highest development phase Phase 2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| MORAb-202 NCT05613088 | Phase 2 | Neoplasms, Ovarian |
Latest
No recent events.
Follow Morab 202 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.